# CILP

## Relevance tier by entity

|Entity|Tier|Description                           |
|:------:|:----:|--------------------------------------|
|![FL](images/icons/FL_tier2.png)    |2   |relevance in FL not firmly established|

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source       |frequency (%)|
|:------:|:-------------:|:-------------:|
|FL    |GAMBL genomes|0.46         |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |No  |No                   |0.915           |0               |
|DLBCL |No  |No                   |0.460           |0               |
|FL    |No  |No                   |0.000           |0               |


> [!NOTE]
> First described in FL in 2023 by [Russler-Germain DA](https://pubmed.ncbi.nlm.nih.gov/37493986)


View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/CILP_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/CILP_protein_hg38.html)

![image](images/proteinpaint/CILP_NM_003613.svg)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/CILP.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/CILP_hg38.html)

![image](images/proteinpaint/CILP.svg)
## CILP Expression
![image](images/gene_expression/CILP_by_pathology.svg)
<!-- ORIGIN: russler-germainMutationsAssociatedProgression2023a -->
<!-- FL: russler-germainMutationsAssociatedProgression2023a -->
